Dianthus Therapeutics Banner

Event Details

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
Press Release

Guggenheim Second Annual Healthcare Innovation Conference

Nov 11, 2025 3:30 PM EST